Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06446232
Other study ID # 202304120RINC
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2023
Est. completion date August 31, 2029

Study information

Verified date June 2024
Source National Taiwan University Hospital
Contact Yi Jen Liau
Phone 02-23123456
Email u8809032@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This project uses questionnaires to statistically analyze whether influenza vaccination is protective for young children.


Description:

This plan is expected to admit 350 children who are admitted to the emergency department or hospitalized due to influenza and are aged from 6 months (inclusive) to under 18 years old. Vaccine status, statistical analysis of whether the flu vaccine is protective.


Recruitment information / eligibility

Status Recruiting
Enrollment 1
Est. completion date August 31, 2029
Est. primary completion date August 31, 2028
Accepts healthy volunteers
Gender All
Age group 6 Months to 18 Years
Eligibility Inclusion Criteria: - Clinical diagnosis of influenza by Flu A+B rapid antigen test - Known vaccination status Exclusion Criteria: - Unknown vaccination status

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Questionnaires This project uses questionnaires to statistically analyze whether the flu vaccine is protective for young children. Researchers collect flu rapid test results and invite subjects to write questionnaires. Data collectors administered a standardised questionnaire that included information on demographics, medical history (including flu vaccination status and self-reported prior flu infection). 12 months
See also
  Status Clinical Trial Phase
Completed NCT03654937 - Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes Phase 4
Completed NCT01310374 - Immune Response Study of Influenza Vaccine N/A